ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
FDA approves INREBIC for Myelofibrosis treatment biospectrumasia
August 20, 2019Celgene Corporation has?announced the U.S. Food and Drug Administration (FDA) has approved INREBIC??(fedratinib) for the treatment of adult patients with intermediate-2 or high-risk primary or secondary (post-polycythemia vera or post-essential thrombocyt
Pharma Sources Insight July 2025
